These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16865406)

  • 1. Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray.
    Bibeau F; Boissière-Michot F; Sabourin JC; Gourgou-Bourgade S; Radal M; Penault-Llorca F; Rochaix P; Arnould L; Bralet MP; Azria D; Ychou M
    Virchows Arch; 2006 Sep; 449(3):281-7. PubMed ID: 16865406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy.
    Wei Q; Shui Y; Zheng S; Wester K; Nordgren H; Nygren P; Glimelius B; Carlsson J
    Oncol Rep; 2011 Jan; 25(1):3-11. PubMed ID: 21109951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Fabris G; Cascinu S
    J Clin Oncol; 2004 Dec; 22(23):4772-8. PubMed ID: 15570078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases.
    Kuramochi H; Hayashi K; Nakajima G; Kamikozuru H; Yamamoto M; Danenberg KD; Danenberg PV
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):825-31. PubMed ID: 19701635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
    Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
    Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections.
    Atkins D; Reiffen KA; Tegtmeier CL; Winther H; Bonato MS; Störkel S
    J Histochem Cytochem; 2004 Jul; 52(7):893-901. PubMed ID: 15208356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor (EGFR) downstream signalling pathway in primary colorectal tumours and related metastatic sites: optimising EGFR-targeted treatment options.
    Scartozzi M; Bearzi I; Berardi R; Mandolesi A; Pierantoni C; Cascinu S
    Br J Cancer; 2007 Jul; 97(1):92-7. PubMed ID: 17579627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor expression in pancreatic carcinoma using tissue microarray technique.
    Bloomston M; Bhardwaj A; Ellison EC; Frankel WL
    Dig Surg; 2006; 23(1-2):74-9. PubMed ID: 16717472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of biological key modulators in primary colorectal carcinomas and related metastatic sites: implications for treatment with cetuximab.
    Barbier A; Domont J; Magné N; Goldmard JL; Genestie C; Hannoun C; Vaillant JC; Bellanger A; Khayat D; Capron F; Spano JP
    Bull Cancer; 2010 Feb; 97(2):E9-E15. PubMed ID: 20085858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human epidermal growth factor receptor-2 family in colorectal adenocarcinoma: correlation with survival and clinicopathological findings.
    Molaei M; Pejhan S; Nayer BN; Moradi A; Ghiasi S; Zali MR
    Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):289-93. PubMed ID: 19279475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa.
    Bhargava R; Chen B; Klimstra DS; Saltz LB; Hedvat C; Tang LH; Gerald W; Teruya-Feldstein J; Paty PB; Qin J; Shia J
    Cancer; 2006 Apr; 106(8):1857-62. PubMed ID: 16532444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there an immunohistochemical technique definitively valid in epidermal growth factor receptor assessment?
    Penault-Llorca F; Cayre A; Arnould L; Bibeau F; Bralet MP; Rochaix P; Savary J; Sabourin JC
    Oncol Rep; 2006 Dec; 16(6):1173-9. PubMed ID: 17089034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
    Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
    Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
    Goetz M; Ziebart A; Foersch S; Vieth M; Waldner MJ; Delaney P; Galle PR; Neurath MF; Kiesslich R
    Gastroenterology; 2010 Feb; 138(2):435-46. PubMed ID: 19852961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.
    Ljuslinder I; Malmer B; Isaksson-Mettävainio M; Oberg A; Henriksson R; Stenling R; Palmqvist R
    Anticancer Res; 2009 May; 29(5):1489-94. PubMed ID: 19443355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites: a new perspective for an "old" therapeutic target.
    Scartozzi M; Bearzi I; Mandolesi A; Galizia E; Pierantoni C; Loupakis F; Berardi R; Zaniboni A; Quadri A; Zorzi F; Biagetti S; Loretelli C; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
    Anal Quant Cytol Histol; 2009 Dec; 31(6):417-23. PubMed ID: 20698358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.
    Kim JY; Bae BN; Kwon JE; Kim HJ; Park K
    APMIS; 2011 Jul; 119(7):449-59. PubMed ID: 21635552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy number.
    Italiano A; Follana P; Caroli FX; Badetti JL; Benchimol D; Garnier G; Gugenheim J; Haudebourg J; Keslair F; Lesbats G; Lledo G; Roussel JF; Pedeutour F; François E
    Ann Surg Oncol; 2008 Feb; 15(2):649-54. PubMed ID: 17987340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.